Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Open in API
Filings indexed 2,231 across all filing types
Latest filing 2025-07-09 Regulatory Filings
Country TW Taiwan
Listing TW 1789

About SPT

https://www.scinopharm.com/tw

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
114年6月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 神隆, providing information on loan balances and endorsement guarantees for the current and previous month, including limits and cumulative amounts. The content is concise, numerical, and regulatory in nature, without detailed financial statements or management discussion. It does not present a full report but rather a regulatory disclosure of specific financial data points. Given the short length (608 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS), which is a general category for regulatory announcements and compliance documents that do not fit other specific categories.
2025-07-09 Chinese
114年6月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 神隆 for the period of June 2025 (民國114年06月). It includes comparative figures from the previous year and percentage changes. The document is short (776 characters) and primarily presents financial summary data without detailed financial statements or analysis. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR). It also does not contain any narrative management discussion or detailed disclosures. Given the nature of the data and the short length, this document fits best as a Regulatory Filing (RNS), which is a general category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2025-07-09 Chinese
114年06月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tabular data showing shareholdings of insiders, including directors, chairman, general manager, and independent directors, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share ownership and transactions, not on financial results, management commentary, or meeting materials. There is no indication of an earnings release, annual report, or other financial report. The document is not a brief announcement but a detailed insider shareholding report. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades).
2025-07-08 Chinese
114年06月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It focuses on the current and initial shareholdings, pledged shares, and related ratios. There is no indication of financial results, earnings, management discussion, or other report content. The document is a disclosure of insider shareholdings and pledges, which aligns with reporting on personal share transactions or holdings by company directors and executives. Therefore, it fits the category of Director's Dealing (DIRS). The document length is sufficient and contains substantive data, not just an announcement or certification.
2025-07-08 Chinese
公告本公司代理發言人、會計主管、財務主管及公司治理 主管異動
Board/Management Information Classification · 100% confidence The document is a company announcement about changes in key personnel positions including proxy spokesperson, accounting supervisor, financial supervisor, and corporate governance supervisor. It details the old and new appointees, reasons for changes, and effective dates. There is no financial data, report, or presentation content. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2025-06-30 Chinese
114年年報及股東會資料 — 2024_1789_20250528FE4.pdf
Regulatory Filings
2025-06-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.